Ikeda and Suzuki's Glutamic Acid Electrolysis Patent, Read Back After a Century of Umami Science
Note on this format: This memo records what I confirmed at the patent URL, with Claim 1, inventor, filing date, and grant date retrieved from Google Patents. The full specification (electrolysis cell diagrams, current density, yield data) is unread. Verified facts only; speculation is labeled as such.
Why Dig This
In 2026, "umami" is internationally established as the fifth basic taste, and L-monosodium glutamate (MSG) is a global food-additive market exceeding three million tonnes per year. The starting point is 1908: Kikunae Ikeda at Tokyo Imperial University isolated L-glutamic acid from kombu (kelp) broth and confirmed its salt as a flavor compound (Japanese patent 14805, partially covered in ep10 "Kitchen Health Archaeology #1"). This memo addresses the US patent for commercial manufacturing — US1015891A — filed jointly by Ikeda and Saburosuke Suzuki (founder of Suzuki Pharmaceutical, today's Ajinomoto) in 1911, granted in 1912. The dig separates the "discovery paper plus Japanese patent" from the "commercial-manufacturing US patent" so the IP path of umami industrialization can be confirmed in primary sources.
Database Correction: The Substantive Patent Is US1015891A
The candidates.tsv entry lists the URL as https://patents.google.com/patent/JP1908000009380, which returns 404 on Google Patents (likely a malformed identifier). I'm adopting US1015891A (filed 1911, Ikeda/Suzuki joint) as the substantive primary source. Treat the 1908 Japanese patent (JP14805) as the discovery patent, and the 1911 US patent (US1015891A) as the commercial-manufacturing patent — two different filings with different functions. Adding to the database-correction sequence from Day 8 onward.
Patent Basics
- Patent number: US1015891A
- Title: Process of separating glutamic acid and other products of hydrolysis of albuminous substances from one another by electrolysis
- Filed: May 2, 1911
- Granted: January 30, 1912
- Inventors: Kikunae Ikeda, Saburosuke Suzuki (joint)
- Original assignee: Individual (held jointly by Ikeda and Suzuki); transfer to Suzuki Pharmaceutical (later Ajinomoto Co., Inc.) — date not confirmed in this memo
- Primary source: Google Patents (URL confirmed; Claim 1 retrieved)
Claim 1 (Summary from Primary Source)
The process of separating the products of hydrolysis of albuminous substances into three groups of compounds based on their chemical character (basic, acidic, and neutral).
The process uses a three-compartment electrolysis cell with a corrodible-metal anode. Hydrolyzed albumin (protein) is separated by exploiting the ionization properties of basic, acidic, and neutral compounds — extracting glutamic acid (an acidic amino acid) industrially.
Relationship to the 1908 Discovery Patent
| Patent | Function | Inventor(s) | Content |
|---|---|---|---|
| Japanese Patent 14805 (1908) | Discovery / use patent | Kikunae Ikeda (sole) | L-glutamic acid isolated from kombu broth, claimed as a flavor compound |
| US1015891A (1911) | Manufacturing process patent | Kikunae Ikeda and Saburosuke Suzuki (joint) | Three-group electrolytic separation of hydrolyzed protein, the purification process needed for commercial production |
Ep10 ("Kitchen Health Archaeology #1") covered the discovery side. This memo records the commercial-manufacturing side as a separate axis.
Connections to Today (Hypothesis)
| US1015891A (1911) | Modern technology / context | Assessment |
|---|---|---|
| Three-group electrolytic separation | Modern MSG production (fermentation using Corynebacterium glutamicum) | Analogy (different process, same target compound) |
| Joint Ikeda/Suzuki filing (academic + industry) | Modern industry/academia partnerships and university spinouts | Similar |
| Asia-to-US patent filing in 1911 | Modern US filings by Chinese, Korean, and Japanese firms | Similar |
| Scientific isolation → commercialization of umami | International recognition of the fifth basic taste (T1R1/T1R3 receptor research, 2000s) | Analogy (receptor research is a different lineage) |
Pitfalls
Pitfall 1: Don't conflate 1908 with 1911. The "1908" in the database refers to the Japanese discovery patent (JP14805). This memo's US1015891A was filed in 1911 and granted in 1912 — three years later, with a different function.
Pitfall 2: The shift from electrolysis to fermentation. The electrolysis process in this patent dominated MSG production from 1909 through the 1950s. In 1956, Kyowa Hakko established microbial fermentation using Corynebacterium glutamicum, and modern MSG production is now almost entirely fermentation-based. No current commercial production directly follows Claim 1 of this patent.
Pitfall 3: "Chinese Restaurant Syndrome" is out of scope. The 1968 letter to the New England Journal of Medicine that popularized "Chinese Restaurant Syndrome" has not held up under double-blind testing, but this memo does not adjudicate that scientific history. Primary-source scope is limited to the 1908 and 1911 patents.
Unconfirmed
- Full specification text (electrolysis cell diagrams, current density, yield data)
- Patent transfer timeline and rights succession from Suzuki Pharmaceutical to Ajinomoto Co., Inc.
- Forward citation count
- Original text of Japanese Patent 14805 (held by the Japan Patent Office archives)
- Kyowa Hakko's 1956 fermentation-process patent (the filing that obsoleted electrolytic production)
Next Action
When promoting this to a full note, retrieve (a) the full US1015891A specification, (b) JP14805 in original Japanese, (c) Ajinomoto's official corporate-history records on rights succession, (d) Kyowa Hakko's 1956 fermentation patent, and assemble the century-long IP lineage of umami industrialization.
Sources:
- Primary patent: US1015891A on Google Patents
- Food & Health Patent #4 (full note): Aspartame US3492131A
- Food & Health Patent Note #4 (memo): Teflon US2230654A
- Wikipedia: Kikunae Ikeda (https://en.wikipedia.org/wiki/Kikunae_Ikeda)